1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Measles and Rubella (MR) Vaccine Annual Sales 2017-2028 2.1.2 World Current & Future Analysis for Measles and Rubella (MR) Vaccine by Geographic Region, 2017, 2022 & 2028 2.1.3 World Current & Future Analysis for Measles and Rubella (MR) Vaccine by Country/Region, 2017, 2022 & 2028 2.2 Measles and Rubella (MR) Vaccine Segment by Type 2.2.1 MR Vaccine 2.2.2 MRBEV Vaccine 2.3 Measles and Rubella (MR) Vaccine Sales by Type 2.3.1 Global Measles and Rubella (MR) Vaccine Sales Market Share by Type (2017-2022) 2.3.2 Global Measles and Rubella (MR) Vaccine Revenue and Market Share by Type (2017-2022) 2.3.3 Global Measles and Rubella (MR) Vaccine Sale Price by Type (2017-2022) 2.4 Measles and Rubella (MR) Vaccine Segment by Application 2.4.1 Private Distribution Channel 2.4.2 Public Distribution Channel 2.5 Measles and Rubella (MR) Vaccine Sales by Application 2.5.1 Global Measles and Rubella (MR) Vaccine Sale Market Share by Application (2017-2022) 2.5.2 Global Measles and Rubella (MR) Vaccine Revenue and Market Share by Application (2017-2022) 2.5.3 Global Measles and Rubella (MR) Vaccine Sale Price by Application (2017-2022) 3 Global Measles and Rubella (MR) Vaccine by Company 3.1 Global Measles and Rubella (MR) Vaccine Breakdown Data by Company 3.1.1 Global Measles and Rubella (MR) Vaccine Annual Sales by Company (2020-2022) 3.1.2 Global Measles and Rubella (MR) Vaccine Sales Market Share by Company (2020-2022) 3.2 Global Measles and Rubella (MR) Vaccine Annual Revenue by Company (2020-2022) 3.2.1 Global Measles and Rubella (MR) Vaccine Revenue by Company (2020-2022) 3.2.2 Global Measles and Rubella (MR) Vaccine Revenue Market Share by Company (2020-2022) 3.3 Global Measles and Rubella (MR) Vaccine Sale Price by Company 3.4 Key Manufacturers Measles and Rubella (MR) Vaccine Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Measles and Rubella (MR) Vaccine Product Location Distribution 3.4.2 Players Measles and Rubella (MR) Vaccine Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Measles and Rubella (MR) Vaccine by Geographic Region 4.1 World Historic Measles and Rubella (MR) Vaccine Market Size by Geographic Region (2017-2022) 4.1.1 Global Measles and Rubella (MR) Vaccine Annual Sales by Geographic Region (2017-2022) 4.1.2 Global Measles and Rubella (MR) Vaccine Annual Revenue by Geographic Region 4.2 World Historic Measles and Rubella (MR) Vaccine Market Size by Country/Region (2017-2022) 4.2.1 Global Measles and Rubella (MR) Vaccine Annual Sales by Country/Region (2017-2022) 4.2.2 Global Measles and Rubella (MR) Vaccine Annual Revenue by Country/Region 4.3 Americas Measles and Rubella (MR) Vaccine Sales Growth 4.4 APAC Measles and Rubella (MR) Vaccine Sales Growth 4.5 Europe Measles and Rubella (MR) Vaccine Sales Growth 4.6 Middle East & Africa Measles and Rubella (MR) Vaccine Sales Growth 5 Americas 5.1 Americas Measles and Rubella (MR) Vaccine Sales by Country 5.1.1 Americas Measles and Rubella (MR) Vaccine Sales by Country (2017-2022) 5.1.2 Americas Measles and Rubella (MR) Vaccine Revenue by Country (2017-2022) 5.2 Americas Measles and Rubella (MR) Vaccine Sales by Type 5.3 Americas Measles and Rubella (MR) Vaccine Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Measles and Rubella (MR) Vaccine Sales by Region 6.1.1 APAC Measles and Rubella (MR) Vaccine Sales by Region (2017-2022) 6.1.2 APAC Measles and Rubella (MR) Vaccine Revenue by Region (2017-2022) 6.2 APAC Measles and Rubella (MR) Vaccine Sales by Type 6.3 APAC Measles and Rubella (MR) Vaccine Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Measles and Rubella (MR) Vaccine by Country 7.1.1 Europe Measles and Rubella (MR) Vaccine Sales by Country (2017-2022) 7.1.2 Europe Measles and Rubella (MR) Vaccine Revenue by Country (2017-2022) 7.2 Europe Measles and Rubella (MR) Vaccine Sales by Type 7.3 Europe Measles and Rubella (MR) Vaccine Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Measles and Rubella (MR) Vaccine by Country 8.1.1 Middle East & Africa Measles and Rubella (MR) Vaccine Sales by Country (2017-2022) 8.1.2 Middle East & Africa Measles and Rubella (MR) Vaccine Revenue by Country (2017-2022) 8.2 Middle East & Africa Measles and Rubella (MR) Vaccine Sales by Type 8.3 Middle East & Africa Measles and Rubella (MR) Vaccine Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Measles and Rubella (MR) Vaccine 10.3 Manufacturing Process Analysis of Measles and Rubella (MR) Vaccine 10.4 Industry Chain Structure of Measles and Rubella (MR) Vaccine 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Measles and Rubella (MR) Vaccine Distributors 11.3 Measles and Rubella (MR) Vaccine Customer 12 World Forecast Review for Measles and Rubella (MR) Vaccine by Geographic Region 12.1 Global Measles and Rubella (MR) Vaccine Market Size Forecast by Region 12.1.1 Global Measles and Rubella (MR) Vaccine Forecast by Region (2023-2028) 12.1.2 Global Measles and Rubella (MR) Vaccine Annual Revenue Forecast by Region (2023-2028) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Measles and Rubella (MR) Vaccine Forecast by Type 12.7 Global Measles and Rubella (MR) Vaccine Forecast by Application 13 Key Players Analysis 13.1 PT Bio Farma 13.1.1 PT Bio Farma Company Information 13.1.2 PT Bio Farma Measles and Rubella (MR) Vaccine Product Offered 13.1.3 PT Bio Farma Measles and Rubella (MR) Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.1.4 PT Bio Farma Main Business Overview 13.1.5 PT Bio Farma Latest Developments 13.2 Bio-Manguinhos 13.2.1 Bio-Manguinhos Company Information 13.2.2 Bio-Manguinhos Measles and Rubella (MR) Vaccine Product Offered 13.2.3 Bio-Manguinhos Measles and Rubella (MR) Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.2.4 Bio-Manguinhos Main Business Overview 13.2.5 Bio-Manguinhos Latest Developments 13.3 BE Vaccines 13.3.1 BE Vaccines Company Information 13.3.2 BE Vaccines Measles and Rubella (MR) Vaccine Product Offered 13.3.3 BE Vaccines Measles and Rubella (MR) Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.3.4 BE Vaccines Main Business Overview 13.3.5 BE Vaccines Latest Developments 13.4 Crucell Switzerland AG 13.4.1 Crucell Switzerland AG Company Information 13.4.2 Crucell Switzerland AG Measles and Rubella (MR) Vaccine Product Offered 13.4.3 Crucell Switzerland AG Measles and Rubella (MR) Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.4.4 Crucell Switzerland AG Main Business Overview 13.4.5 Crucell Switzerland AG Latest Developments 14 Research Findings and Conclusion

List of Tables Table 1. Measles and Rubella (MR) Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions) Table 2. Measles and Rubella (MR) Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions) Table 3. Major Players of MR Vaccine Table 4. Major Players of MRBEV Vaccine Table 5. Global Measles and Rubella (MR) Vaccine Sales by Type (2017-2022) & (Units) Table 6. Global Measles and Rubella (MR) Vaccine Sales Market Share by Type (2017-2022) Table 7. Global Measles and Rubella (MR) Vaccine Revenue by Type (2017-2022) & ($ million) Table 8. Global Measles and Rubella (MR) Vaccine Revenue Market Share by Type (2017-2022) Table 9. Global Measles and Rubella (MR) Vaccine Sale Price by Type (2017-2022) & (US$/Unit) Table 10. Global Measles and Rubella (MR) Vaccine Sales by Application (2017-2022) & (Units) Table 11. Global Measles and Rubella (MR) Vaccine Sales Market Share by Application (2017-2022) Table 12. Global Measles and Rubella (MR) Vaccine Revenue by Application (2017-2022) Table 13. Global Measles and Rubella (MR) Vaccine Revenue Market Share by Application (2017-2022) Table 14. Global Measles and Rubella (MR) Vaccine Sale Price by Application (2017-2022) & (US$/Unit) Table 15. Global Measles and Rubella (MR) Vaccine Sales by Company (2020-2022) & (Units) Table 16. Global Measles and Rubella (MR) Vaccine Sales Market Share by Company (2020-2022) Table 17. Global Measles and Rubella (MR) Vaccine Revenue by Company (2020-2022) ($ Millions) Table 18. Global Measles and Rubella (MR) Vaccine Revenue Market Share by Company (2020-2022) Table 19. Global Measles and Rubella (MR) Vaccine Sale Price by Company (2020-2022) & (US$/Unit) Table 20. Key Manufacturers Measles and Rubella (MR) Vaccine Producing Area Distribution and Sales Area Table 21. Players Measles and Rubella (MR) Vaccine Products Offered Table 22. Measles and Rubella (MR) Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) Table 23. New Products and Potential Entrants Table 24. Mergers & Acquisitions, Expansion Table 25. Global Measles and Rubella (MR) Vaccine Sales by Geographic Region (2017-2022) & (Units) Table 26. Global Measles and Rubella (MR) Vaccine Sales Market Share Geographic Region (2017-2022) Table 27. Global Measles and Rubella (MR) Vaccine Revenue by Geographic Region (2017-2022) & ($ millions) Table 28. Global Measles and Rubella (MR) Vaccine Revenue Market Share by Geographic Region (2017-2022) Table 29. Global Measles and Rubella (MR) Vaccine Sales by Country/Region (2017-2022) & (Units) Table 30. Global Measles and Rubella (MR) Vaccine Sales Market Share by Country/Region (2017-2022) Table 31. Global Measles and Rubella (MR) Vaccine Revenue by Country/Region (2017-2022) & ($ millions) Table 32. Global Measles and Rubella (MR) Vaccine Revenue Market Share by Country/Region (2017-2022) Table 33. Americas Measles and Rubella (MR) Vaccine Sales by Country (2017-2022) & (Units) Table 34. Americas Measles and Rubella (MR) Vaccine Sales Market Share by Country (2017-2022) Table 35. Americas Measles and Rubella (MR) Vaccine Revenue by Country (2017-2022) & ($ Millions) Table 36. Americas Measles and Rubella (MR) Vaccine Revenue Market Share by Country (2017-2022) Table 37. Americas Measles and Rubella (MR) Vaccine Sales by Type (2017-2022) & (Units) Table 38. Americas Measles and Rubella (MR) Vaccine Sales Market Share by Type (2017-2022) Table 39. Americas Measles and Rubella (MR) Vaccine Sales by Application (2017-2022) & (Units) Table 40. Americas Measles and Rubella (MR) Vaccine Sales Market Share by Application (2017-2022) Table 41. APAC Measles and Rubella (MR) Vaccine Sales by Region (2017-2022) & (Units) Table 42. APAC Measles and Rubella (MR) Vaccine Sales Market Share by Region (2017-2022) Table 43. APAC Measles and Rubella (MR) Vaccine Revenue by Region (2017-2022) & ($ Millions) Table 44. APAC Measles and Rubella (MR) Vaccine Revenue Market Share by Region (2017-2022) Table 45. APAC Measles and Rubella (MR) Vaccine Sales by Type (2017-2022) & (Units) Table 46. APAC Measles and Rubella (MR) Vaccine Sales Market Share by Type (2017-2022) Table 47. APAC Measles and Rubella (MR) Vaccine Sales by Application (2017-2022) & (Units) Table 48. APAC Measles and Rubella (MR) Vaccine Sales Market Share by Application (2017-2022) Table 49. Europe Measles and Rubella (MR) Vaccine Sales by Country (2017-2022) & (Units) Table 50. Europe Measles and Rubella (MR) Vaccine Sales Market Share by Country (2017-2022) Table 51. Europe Measles and Rubella (MR) Vaccine Revenue by Country (2017-2022) & ($ Millions) Table 52. Europe Measles and Rubella (MR) Vaccine Revenue Market Share by Country (2017-2022) Table 53. Europe Measles and Rubella (MR) Vaccine Sales by Type (2017-2022) & (Units) Table 54. Europe Measles and Rubella (MR) Vaccine Sales Market Share by Type (2017-2022) Table 55. Europe Measles and Rubella (MR) Vaccine Sales by Application (2017-2022) & (Units) Table 56. Europe Measles and Rubella (MR) Vaccine Sales Market Share by Application (2017-2022) Table 57. Middle East & Africa Measles and Rubella (MR) Vaccine Sales by Country (2017-2022) & (Units) Table 58. Middle East & Africa Measles and Rubella (MR) Vaccine Sales Market Share by Country (2017-2022) Table 59. Middle East & Africa Measles and Rubella (MR) Vaccine Revenue by Country (2017-2022) & ($ Millions) Table 60. Middle East & Africa Measles and Rubella (MR) Vaccine Revenue Market Share by Country (2017-2022) Table 61. Middle East & Africa Measles and Rubella (MR) Vaccine Sales by Type (2017-2022) & (Units) Table 62. Middle East & Africa Measles and Rubella (MR) Vaccine Sales Market Share by Type (2017-2022) Table 63. Middle East & Africa Measles and Rubella (MR) Vaccine Sales by Application (2017-2022) & (Units) Table 64. Middle East & Africa Measles and Rubella (MR) Vaccine Sales Market Share by Application (2017-2022) Table 65. Key Market Drivers & Growth Opportunities of Measles and Rubella (MR) Vaccine Table 66. Key Market Challenges & Risks of Measles and Rubella (MR) Vaccine Table 67. Key Industry Trends of Measles and Rubella (MR) Vaccine Table 68. Measles and Rubella (MR) Vaccine Raw Material Table 69. Key Suppliers of Raw Materials Table 70. Measles and Rubella (MR) Vaccine Distributors List Table 71. Measles and Rubella (MR) Vaccine Customer List Table 72. Global Measles and Rubella (MR) Vaccine Sales Forecast by Region (2023-2028) & (Units) Table 73. Global Measles and Rubella (MR) Vaccine Sales Market Forecast by Region Table 74. Global Measles and Rubella (MR) Vaccine Revenue Forecast by Region (2023-2028) & ($ millions) Table 75. Global Measles and Rubella (MR) Vaccine Revenue Market Share Forecast by Region (2023-2028) Table 76. Americas Measles and Rubella (MR) Vaccine Sales Forecast by Country (2023-2028) & (Units) Table 77. Americas Measles and Rubella (MR) Vaccine Revenue Forecast by Country (2023-2028) & ($ millions) Table 78. APAC Measles and Rubella (MR) Vaccine Sales Forecast by Region (2023-2028) & (Units) Table 79. APAC Measles and Rubella (MR) Vaccine Revenue Forecast by Region (2023-2028) & ($ millions) Table 80. Europe Measles and Rubella (MR) Vaccine Sales Forecast by Country (2023-2028) & (Units) Table 81. Europe Measles and Rubella (MR) Vaccine Revenue Forecast by Country (2023-2028) & ($ millions) Table 82. Middle East & Africa Measles and Rubella (MR) Vaccine Sales Forecast by Country (2023-2028) & (Units) Table 83. Middle East & Africa Measles and Rubella (MR) Vaccine Revenue Forecast by Country (2023-2028) & ($ millions) Table 84. Global Measles and Rubella (MR) Vaccine Sales Forecast by Type (2023-2028) & (Units) Table 85. Global Measles and Rubella (MR) Vaccine Sales Market Share Forecast by Type (2023-2028) Table 86. Global Measles and Rubella (MR) Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions) Table 87. Global Measles and Rubella (MR) Vaccine Revenue Market Share Forecast by Type (2023-2028) Table 88. Global Measles and Rubella (MR) Vaccine Sales Forecast by Application (2023-2028) & (Units) Table 89. Global Measles and Rubella (MR) Vaccine Sales Market Share Forecast by Application (2023-2028) Table 90. Global Measles and Rubella (MR) Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions) Table 91. Global Measles and Rubella (MR) Vaccine Revenue Market Share Forecast by Application (2023-2028) Table 92. PT Bio Farma Basic Information, Measles and Rubella (MR) Vaccine Manufacturing Base, Sales Area and Its Competitors Table 93. PT Bio Farma Measles and Rubella (MR) Vaccine Product Offered Table 94. PT Bio Farma Measles and Rubella (MR) Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 95. PT Bio Farma Main Business Table 96. PT Bio Farma Latest Developments Table 97. Bio-Manguinhos Basic Information, Measles and Rubella (MR) Vaccine Manufacturing Base, Sales Area and Its Competitors Table 98. Bio-Manguinhos Measles and Rubella (MR) Vaccine Product Offered Table 99. Bio-Manguinhos Measles and Rubella (MR) Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 100. Bio-Manguinhos Main Business Table 101. Bio-Manguinhos Latest Developments Table 102. BE Vaccines Basic Information, Measles and Rubella (MR) Vaccine Manufacturing Base, Sales Area and Its Competitors Table 103. BE Vaccines Measles and Rubella (MR) Vaccine Product Offered Table 104. BE Vaccines Measles and Rubella (MR) Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 105. BE Vaccines Main Business Table 106. BE Vaccines Latest Developments Table 107. Crucell Switzerland AG Basic Information, Measles and Rubella (MR) Vaccine Manufacturing Base, Sales Area and Its Competitors Table 108. Crucell Switzerland AG Measles and Rubella (MR) Vaccine Product Offered Table 109. Crucell Switzerland AG Measles and Rubella (MR) Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 110. Crucell Switzerland AG Main Business Table 111. Crucell Switzerland AG Latest Developments List of Figures Figure 1. Picture of Measles and Rubella (MR) Vaccine Figure 2. Measles and Rubella (MR) Vaccine Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Measles and Rubella (MR) Vaccine Sales Growth Rate 2017-2028 (Units) Figure 7. Global Measles and Rubella (MR) Vaccine Revenue Growth Rate 2017-2028 ($ Millions) Figure 8. Measles and Rubella (MR) Vaccine Sales by Region (2021 & 2028) & ($ millions) Figure 9. Product Picture of MR Vaccine Figure 10. Product Picture of MRBEV Vaccine Figure 11. Global Measles and Rubella (MR) Vaccine Sales Market Share by Type in 2021 Figure 12. Global Measles and Rubella (MR) Vaccine Revenue Market Share by Type (2017-2022) Figure 13. Measles and Rubella (MR) Vaccine Consumed in Private Distribution Channel Figure 14. Global Measles and Rubella (MR) Vaccine Market: Private Distribution Channel (2017-2022) & (Units) Figure 15. Measles and Rubella (MR) Vaccine Consumed in Public Distribution Channel Figure 16. Global Measles and Rubella (MR) Vaccine Market: Public Distribution Channel (2017-2022) & (Units) Figure 17. Global Measles and Rubella (MR) Vaccine Sales Market Share by Application (2017-2022) Figure 18. Global Measles and Rubella (MR) Vaccine Revenue Market Share by Application in 2021 Figure 19. Measles and Rubella (MR) Vaccine Revenue Market by Company in 2021 ($ Million) Figure 20. Global Measles and Rubella (MR) Vaccine Revenue Market Share by Company in 2021 Figure 21. Global Measles and Rubella (MR) Vaccine Sales Market Share by Geographic Region (2017-2022) Figure 22. Global Measles and Rubella (MR) Vaccine Revenue Market Share by Geographic Region in 2021 Figure 23. Global Measles and Rubella (MR) Vaccine Sales Market Share by Region (2017-2022) Figure 24. Global Measles and Rubella (MR) Vaccine Revenue Market Share by Country/Region in 2021 Figure 25. Americas Measles and Rubella (MR) Vaccine Sales 2017-2022 (Units) Figure 26. Americas Measles and Rubella (MR) Vaccine Revenue 2017-2022 ($ Millions) Figure 27. APAC Measles and Rubella (MR) Vaccine Sales 2017-2022 (Units) Figure 28. APAC Measles and Rubella (MR) Vaccine Revenue 2017-2022 ($ Millions) Figure 29. Europe Measles and Rubella (MR) Vaccine Sales 2017-2022 (Units) Figure 30. Europe Measles and Rubella (MR) Vaccine Revenue 2017-2022 ($ Millions) Figure 31. Middle East & Africa Measles and Rubella (MR) Vaccine Sales 2017-2022 (Units) Figure 32. Middle East & Africa Measles and Rubella (MR) Vaccine Revenue 2017-2022 ($ Millions) Figure 33. Americas Measles and Rubella (MR) Vaccine Sales Market Share by Country in 2021 Figure 34. Americas Measles and Rubella (MR) Vaccine Revenue Market Share by Country in 2021 Figure 35. United States Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 36. Canada Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 37. Mexico Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 38. Brazil Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 39. APAC Measles and Rubella (MR) Vaccine Sales Market Share by Region in 2021 Figure 40. APAC Measles and Rubella (MR) Vaccine Revenue Market Share by Regions in 2021 Figure 41. China Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 42. Japan Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 43. South Korea Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 44. Southeast Asia Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 45. India Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 46. Australia Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 47. Europe Measles and Rubella (MR) Vaccine Sales Market Share by Country in 2021 Figure 48. Europe Measles and Rubella (MR) Vaccine Revenue Market Share by Country in 2021 Figure 49. Germany Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 50. France Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 51. UK Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 52. Italy Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 53. Russia Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 54. Middle East & Africa Measles and Rubella (MR) Vaccine Sales Market Share by Country in 2021 Figure 55. Middle East & Africa Measles and Rubella (MR) Vaccine Revenue Market Share by Country in 2021 Figure 56. Egypt Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 57. South Africa Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 58. Israel Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 59. Turkey Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 60. GCC Country Measles and Rubella (MR) Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 61. Manufacturing Cost Structure Analysis of Measles and Rubella (MR) Vaccine in 2021 Figure 62. Manufacturing Process Analysis of Measles and Rubella (MR) Vaccine Figure 63. Industry Chain Structure of Measles and Rubella (MR) Vaccine Figure 64. Channels of Distribution Figure 65. Distributors Profiles